Certification
of CFO Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section
906 of
the Sarbanes-Oxley Act of 2002
In
connection with the Quarterly Report of BioSante Pharmaceuticals, Inc.
(the
“Company”) on Form 10-Q for the quarterly period ended June 30,
2005
as filed with the Securities and Exchange Commission on the date hereof
(the
“Report”), I, Phillip B. Donenberg, Chief Financial Officer, Treasurer and
Secretary of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the
best of
my knowledge:
(1) The
Report fully complies with the requirements of Section 13(a) or 15(d)
of the
Securities Exchange Act of 1934; and
(2) The
information contained in the Report fairly presents, in all material
respects,
the financial condition and results of operations of the Company.
Date: August
12, 2005
/s/
Phillip B. Donenberg
Phillip
B. Donenberg
Chief
Financial Officer, Treasurer and Secretary